Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02117219
Title Phase 1 Study to Evaluate MEDI4736 in MDS
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC

myelodysplastic syndrome


Azacitidine + Durvalumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.